Working… Menu

A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01731301
Recruitment Status : Unknown
Verified November 2012 by Liver Institute of Virginia.
Recruitment status was:  Not yet recruiting
First Posted : November 21, 2012
Last Update Posted : November 22, 2012
Merck Sharp & Dohme Corp.
Chronic Liver Disease Foundation
Information provided by (Responsible Party):
Liver Institute of Virginia

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : January 2014
Estimated Study Completion Date : January 2015